Aova and Europharma Partner to Distribute Feed Additive in North America
Aova Technologies, Inc. has partnered with Europharma, a Norwegian subsidiary of Nordly Holdings, to distribute the BIG FISH branded additive to aquaculture markets in North America. With a focus on generating salmonoid performance data, Aova and Europharma are poised to penetrate the worldwide salmon markets, which account for approximately two million metric tons of fish feed annually.
“The partnership between Aova and Europharma will provide aquaculture producers in the United States and Central America with our valued added feed additive to meet the growing demands of this important region as it continues to grow and expand quality production of different fish species. We are honored to be working with an outstanding company like Europharma and an outstanding Technical Services
Team”, added Jesus Martinez, President & CEO of Aova Technologies.
Big Fish, as well as Aova’s other and similarly named “Big” product lines designed as feed additives for poultry, calves and swine, is a host targeted specialized immunoglobulin. When added to livestock and aquaculture feed, the supplement improves the intestinal health of animals raised in controlled environments by reducing the inflammatory response. The additive diverts a larger percentage of an animal’s metabolic resources to increase and accelerate its growth, while also reducing overall caloric demands. “Europharma is very pleased to bring the Aova technology platform to salmon producers around the world.
BIG FISH offers salmon producers a powerful tool to naturally improve salmon health and performance”, added Claudio Retamal, General Manager of Europharma.
Europharma is the leading wholesaler and supplier of fish health products for the Norwegian fish farming Industry. Europharma additionally holds a significant position in all other important salmon producing markets through Europharma Chile S.A., Europharma Inc (North America) and Europharma Scotland LTD.
